This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Liao XC, Littman DR . Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 1995; 3: 757–769.
Lucas JA, Miller AT, Atherly LO, Berg LJ . The role of Tec family kinases in T cell development and function. Immunol Rev 2003; 191: 119–138.
Huck K, Feyen O, Niehues T, Rüschendorf F, Hübner N, Laws HJ et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 2009; 119: 1350–1358.
Ghosh S, Bienemann K, Boztug K, Borkhardt A . Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects. J Clin Immunol 2014; 34: 892–899.
Linka RM, Risse SL, Bienemann K, Werner M, Linka Y, Krux F et al. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia 2012; 26: 963–971.
Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234–1243.
Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM . Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993; 81: 2102–2109.
Chung BK, Tsai K, Allan LL, Zheng DJ, Nie JC, Biggs CM et al. Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood 2013; 122: 2600–2608.
Moosmann A, Bigalke I, Tischer J, Schirrmann L, Kasten J, Tippmer S et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood 2010; 115: 2960–2970.
Mansouri D, Mahdaviani SA, Khalilzadeh S, Mohajerani SA, Hasanzad M, Sadr S et al. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection. Int Arch Allergy Immunol 2012; 158: 418–422.
Stepensky P, Weintraub M, Yanir A, Revel-Vilk S, Krux F, Huck K et al. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica 2011; 96: 472–476.
Shamriz O, Vilk SR, Wolf DG, Ta-Shma A, Averbuch D, Weintraub M et al. Hematopoietic stem cell transplantation conditioning with use of rituximab in EBV related lymphoproliferative disorders. Clin Immunol 2014; 151: 79–83.
Katzenstein AL, Peiper SC . Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique. Mod Pathol 1990; 3: 435–441.
Do KH, Lee JS, Seo JB, Song JW, Chung MJ, Heo JN et al. Pulmonary parenchymal involvement of low-grade lymphoproliferative disorders. J Comput Assist Tomogr 2005; 29: 825–830.
Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112: 973–980.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Çağdaş, D., Erman, B., Hanoğlu, D. et al. Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other. Bone Marrow Transplant 52, 126–129 (2017). https://doi.org/10.1038/bmt.2016.185
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.185
This article is cited by
-
Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect
Journal of Clinical Immunology (2020)